Related references
Note: Only part of the references are listed.How the COVID-19 pandemic has changed our lives: A study of psychological correlates across 59 countries
Elisabet Alzueta et al.
JOURNAL OF CLINICAL PSYCHOLOGY (2021)
A novel coronavirus outbreak of global health concern
Chen Wang et al.
LANCET (2020)
How we should respond to the Coronavirus SARS-CoV-2 outbreak: A German perspective
F. Jung et al.
CLINICAL HEMORHEOLOGY AND MICROCIRCULATION (2020)
Utility of maximum inspiratory and expiratory pressures as a screening method for respiratory insufficiency in slowly progressive neuromuscular disorders
Stephan Wenninger et al.
NEUROMUSCULAR DISORDERS (2020)
The German healthcare system and the coronavirus pandemic-comments from a legal perspective
F. Knieps
UROLOGE (2020)
SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat
Jun Zheng
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
36-Months follow-up assessment after cessation and resuming of enzyme replacement therapy in late onset Pompe disease: data from the Swiss Pompe Registry
Olivier Scheidegger et al.
JOURNAL OF NEUROLOGY (2018)
Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis
Benedikt Schoser et al.
JOURNAL OF NEUROLOGY (2017)
Maximum inspiratory pressure as a clinically meaningful trial endpoint for neuromuscular diseases: a comprehensive review of the literature
Benedikt Schoser et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Erratum: ATS Statement: Guidelines for the Six-Minute Walk Test
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Neuropathology in respiratory-related motoneurons in young Pompe (Gaa-/-) mice
Sara M. F. Turner et al.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2016)
Cessation and resuming of alglucosidase alfa in Pompe disease: a retrospective analysis
Thomas Hundsberger et al.
JOURNAL OF NEUROLOGY (2014)
Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study
Deniz Gungor et al.
ORPHANET JOURNAL OF RARE DISEASES (2013)
Supine volume drop and diaphragmatic function in adults with Pompe disease
Helene Prigent et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study
Nadine A. M. E. van der Beek et al.
ORPHANET JOURNAL OF RARE DISEASES (2012)
Aids to the Investigation of Peripheral Nerve Injuries. Medical Research Council: Nerve Injuries Research Committee. His Majesty's Stationery Office: 1942; pp. 48 (iii) and 74 figures and 7 diagrams; with Aids to the Examination of the Peripheral Nervous System. By Michael O'Brien for the Guarantors of Brain. Saunders Elsevier: 2010; pp. [8] 64 and 94 Figures
A. Compston
BRAIN (2010)
Lysosomal storage disease 2 - Pompe's disease
Ans T. van der Ploeg et al.
LANCET (2008)
Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial
L Klinge et al.
NEUROMUSCULAR DISORDERS (2005)